1209780-71-1 Usage
General Description
1-Piperidinecarboxylic acid, 3,3-difluoro-4-hydroxy-, 1,1-dimethylethyl ester, also known as teprenone, is a chemical compound used in the pharmaceutical industry. It is a synthetic analogue of geranylgeranyl pyrophosphate (GGPP) and has been studied for its potential anti-aging and protective effects on skin. 1-Piperidinecarboxylic acid, 3,3-difluoro-4-hydroxy-, 1,1-diMethylethyl ester is believed to have antioxidant and anti-inflammatory properties, and it may help to improve the skin's barrier function and reduce the appearance of fine lines and wrinkles. Teprenone has also been investigated for its potential to protect against UV-induced skin damage and to promote wound healing. As a result, it is used in various cosmetic and skincare products for its potential anti-aging and skin-protective properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1209780-71-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,9,7,8 and 0 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1209780-71:
(9*1)+(8*2)+(7*0)+(6*9)+(5*7)+(4*8)+(3*0)+(2*7)+(1*1)=161
161 % 10 = 1
So 1209780-71-1 is a valid CAS Registry Number.
1209780-71-1Relevant articles and documents
5-SUBSTITUTED DIFLUOROPIPERIDINE COMPOUND CAPABLE OF PASSING THROUGH BLOOD-BRAIN BARRIER
-
, (2021/02/18)
The present invention discloses 5-substituted difluoropiperidine compounds having a capacity to cross the blood-brain barrier; the compound has the structural formula represented by formula (I): The 5-substituted difluoropiperidine compounds, derivatives
ERBB RECEPTOR INHIBITORS
-
Page/Page column 78, (2019/11/28)
Disclosed are compounds inhibiting ErbBs (e. g. HER2), pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compound and the pharmaceutical composition can effectively treat diseases associated ErbBs (especially HER2), including cancer.
Bridged Spiro[2.4]heptane Ester Derivatives
-
, (2013/09/12)
The invention relates to a method for preparing linear polymers having an amide end or having a star architecture comprising an amide core, by means of a ring opening using lactide and glycolide monomers or a lactide monomer ring in the presence of a cata